Share Name Share Symbol Market Type Share ISIN Share Description
Valirx LSE:VAL London Ordinary Share GB00BWWYSP41 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.025p -1.15% 2.15p 2.05p 2.25p 2.175p 2.075p 2.125p 617,773 14:07:18
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -5.8 -8.5 - 2.84

Valirx Share Discussion Threads

Showing 19476 to 19498 of 19500 messages
Chat Pages: 780  779  778  777  776  775  774  773  772  771  770  769  Older
DateSubjectAuthorDiscuss
21/7/2017
09:28
"Unfortunately, we have been unable to proceed with your order to buy Valirx plc at a limit price of 2.1 for the following reason: outside market size - 2.15p is indicated in the size" Nice eh, drop the price no problem but do not let anybody buy at it.
love it
21/7/2017
09:23
Drop the bid and offer on one sale but they will not let you buy online.
love it
21/7/2017
08:30
Bet the mm who has just picked up 100k at 2.12p is liking the shake though. It was 2.26p bid yesterday and somebody paid 2.32p over the offer.
love it
21/7/2017
08:18
It is but investors were born to suffer I guess.. "If it looks like a duck, swims like a duck, and quacks like a duck, then it probably is a duck"ValiRx have been a good example..A dog of a share so far.
thebossman
21/7/2017
07:56
Closed 2.25p offer opens 2.15p offer it's hard work being a VAL shareholder the mm's always forcing the price back down.
love it
20/7/2017
13:36
Slashing the price on a £500 sale now. The mm's are not playing fair here
love it
20/7/2017
13:32
2.21-2.212 spread online Cannot really argue with that. I think they are close to clearing out a seller then the price will move more swiftly to 2.5-3p
love it
20/7/2017
13:23
Love it.. No seller it's just ValiRx
thebossman
20/7/2017
13:05
And instantly they shake it on a couple of small sales.
love it
20/7/2017
12:48
Maybe the rise is because we are clearing a seller. Seen some big sales show daily so when they are out this could fly. Nice gap up to 4p if it can break the current flat line on the chart. Looks much more positive than recently.
love it
20/7/2017
12:45
Today 12:27 Price: 2.28 DRAEY 1,522 posts Volume a lot Of big buys . Building stakes. Slowly by big boys. Off Topic No Opinion Reply to post Today 12:20 Price: 2.28 paulie3 1,538 posts re val with good news comes a Re rate upside is huge Off Topic No Opinion Reply to post Today 12:08 Price: 2.28 fourteen14 590 posts val Good to have some positivity here today. Observation Strong Buy Reply to post Today 12:08 Price: 2.28 Noise 2,151 posts hm Tripled volume - rising prices - 3-5 months away from trial results? Perhaps interest is now picking up. It's a lot easier to invest now than 2 years ago Off Topic No Opinion
thebossman
19/7/2017
13:33
Bobby ..Why 2022
thebossman
19/7/2017
12:47
A nice pipe-dream, but these will be bust before 2022.
bobby.ifa
19/7/2017
12:24
Cloud cuckoo land.. Today 11:56 Price: 2.15 paulie3 1,534 posts Addressable market There will clearly have to be a decision to be made at an appropriate time, based on balancing an attractive price that gains high market share against an aggressive price that may limit market share. The key, therefore, will be the efficacy and survival data. For the purposes of modelling we have assumed an annual price of $25k per patient for VAL401. With VAL401, ValiRx and its partner ValiSeek will first target the second line therapeutic segment in NSCLC, probably in combination with a folate anti-metabolite such as pemetrexed (Alimta, Lilly). Given that VAL401 is ‘simply’ a new complex formulation of an existing drug for a new indication, the issue for the commercial partner will be that of price, with the price for traditional risperidone having set a benchmark. However, proven efficacy for VAL401 would allow it to be priced competitively against existing second line therapies for NSCLC, which currently stand in the range $30,000-50,000 p.a. Our assumptions are based on the number of lung cancer patients published by the National Cancer Institute (US) and Eurostat (EU). On current schedules, VAL401 could be on the market around 2022. Our pricing assumption is for an attractive price at the bottom-end of the range for current second-line therapies in order to achieve good market penetration, which will be helped by the extensive safety data already available for the marketed product. On this basis, VAL401 should comfortably achieve annual net sales in excess of $1.0bn. Off Topic No Opinion
thebossman
19/7/2017
12:03
256k@2.2 buy but only 2% up.. Crooked or what
thebossman
19/7/2017
06:07
Josh.. Bit of a silly question don't you think. Sp up and down like a yo yo.. Today 08:42 Price: 2.23 Multibagger1 5,181 posts Entering a defining period The two trials set to conclude this year with updates likely this quarter. If they work value will finally out. Commercially we must be close with trial success. If they don't work well we know how it will pan out. All the signs which have been clinically reported are of trial success. Yet the share price is set for abject failure. So success means a very large rise. Let's hope we have success! Off Topic No Opinion
thebossman
19/7/2017
05:16
Is it still going? !!!!
joshondale
18/7/2017
10:37
Val is a Dodgy stock(proved by facts) a investors nightmare... Hopefully when we get some good news things might change.
thebossman
18/7/2017
10:05
up yet 2-2.2p. I'm sure when I last looked it was around 2.15-2.25p or 2.2p bid so not sure why it's down as low as 2p bid. Saying that I'm getting bid much higher online.
love it
17/7/2017
16:45
Wishful thinking on your part then..One can only hope I guess. Fingers crossed
thebossman
17/7/2017
15:02
It was only 2 years ago I paid 62p for this. It's not like anything terrible has happened since yet it's lost nearly all of it's value due to dilution/fund raisings. 3 mil cap still leaves room for a possible big bounce if any excitement returns on the cancer front.
love it
17/7/2017
14:58
I have managed to drop my average to 19p by buying at the [current] bottom...after all the money I have spent...throwing a few hundred more away doesnt seem so bad....and you do get a lot of shares for a £1K now !
southernstar
17/7/2017
13:35
Love it.. If all the info we have is true then the share price should be well about your estimates.. I've been waiting a long time and my hair has turned grey to boot.
thebossman
Chat Pages: 780  779  778  777  776  775  774  773  772  771  770  769  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20170723 06:52:05